Weight Loss drugs may alter treatment paradigm for chronic disorders, say experts

Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and metabolic diseases such as diabetes and cardiovascular disorders. Hailed for their efficacy, these drugs are helping patients lose significant weight and offer additional health benefits. Experts see them as game-changers in the way some of the chronic conditions are managed by doctors. Caution is however advised to prevent their misuse and dependency. While the medications could complement lifestyle changes and even eliminate the need of bariatric surgery, accessibility and long-term effects remain concerns. Balancing life-changing innovations with responsible use are the key to maximising their positive impact on health.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/qn5wvUF
via gqrds

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018